EMA adopts UK black triangle scheme for pharmacovigilance in most at risk cases
The European Medicines Agency (EMA), the European Union’s medicines regulator, has adopted the UK’s “black triangle” system to highlight those drugs that have potentially bigger dangers of side effects. The move comes as part of the new EU pharmacovigilance laws and is intended to help to highlight and encourage earlier reporting of any particular serious… Learn more